Adenomyosis, IVF
Conditions
Brief summary
The study participants' relevant medical records will be collected and reviewed for the retrospective subjects and after obtaining informed consent for the prospective subjects. The study materials that will be used will include blood tests, transvaginal ultrasound and magnetic resonance imaging (MRI). The study will involve two study arms
Detailed description
The study participants' relevant medical records will be collected and reviewed for the retrospective subjects and after obtaining informed consent for the prospective subjects. The study materials that will be used will include blood tests, transvaginal ultrasound and magnetic resonance imaging (MRI). The study will involve two study arms: Arm 1: Women with adenomyosis pretreated with levonorgestrel-releasing intrauterine device (LNG-IUS) and proceeding with the ICSI Arm 2: Women with adenomyosis pretreated with oral progestin Dienogest and proceeding with the ICSI Primary and secondary key measurements will be used in the study. The primary measures will include: * Presence of intrauterine gestational sac at 12 weeks * Presence of fetal heart pulsation at 12 weeks The secondary key measures will include: * Occurance of abortion in the 1st trimester * Appearance of ectopic pregnancy diagnosis by: Ultrasound Serum β-HCG level Symptoms of pain and bleeding * Two serum β-HCG levels in 48hrs interval to emphasis biochemical pregnancy * Recording the the baseline characteristics of the study participants
Interventions
Intervention is administered proceeding the ICSI
Sponsors
National Research Centre, Egypt
Wael Elbanna Clinic
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
FEMALE
Age
No minimum to 42 Years
Inclusion criteria
1. Patients diagnosed using both the transvaginal ultrasound study (TVS) and MRI criteria * Main criteria for sonographic and MRI diagnosis of adenomyosis are: The appearance of asymmetrical thickening of the myometrium Irregular cystic areas within the myometrium Linear striations radiating out from the myometrium 2. Patients ≤42 years old at the time of starting ICSI cycle 3. Cryopreserved embryo transfer cycles 4. The presence of at least one good cryopreserved day 3 embryo.
Exclusion criteria
1. Transfer of a poor-quality embryo (grades 3 or 4) 2. History of myomectomy 3. Pelvic ultrasound that showed the presence of uterine fibroids, a hydrosalpinx or endometrial polyps (all known causes of implantation failure).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| ongoing pregnancy | up to 13 weeks gestation | \- Recording the following for the two arms of the study: Presence of intrauterine gestational sac at 12 weeks Presence of fetal heart pulsation at 12 weeks |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Occurance of abortion or ectopic | up to 13 weeks gestation | Recording the following for the two arms of the study: Occurance of abortion in the 1st trimester Appearance of ectopic pregnancy diagnosis Two serum β-HCG levels in 48hrs interval |
| Recording the baseline characteristics of the study participants | Before study intervention | age |
Countries
Egypt
Contacts
Primary ContactWael Saad Saad El Banna El Banna, MD
Backup ContactEslam Fathy Fathy, M.Sc.
Outcome results
None listed